Skip to content
April 20, 2024

Equity.Guru

Investment information for the new generation

Search

preclinical testing

Numinus Wellness (NUMI.T) research lab, Numinus Bioscience, received the nod from the Public Health Agency of Canada for their containment level 2 (CL2) pathogens and toxins license after the…
Revive Therapeutics (RVV.C) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. RVV holds 13 patents (issued and…
Revive Therapeutics (RVV.C) signed a research agreement with the University of California, San Francisco (UCSF) to explore Bucillamine as a potential treatment for severe cases of COVID-19 today, according…